Advanced Optics Electronics Buys 21% of Disease Management Co.; Biomoda Moves Into ASR Sales Targeted at European Markets.
Business Wire; 2/19/2004
Read the Full Article, Get a FREE Trial for instant access »
HighBeam Research Members — Log in now
Business Editors/Health/Medical Writers
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Feb. 19, 2004
Advanced Optics Electronics, Inc. (OTCBB:ADOT) has completed the acquisition of approximately 21% of Genomed, Inc., a St. Louis-based publicly traded biotech company. Genomed, Inc. is a Next Generation Disease Management TM company identifying the molecular pathways that cause disease. Genomed has filed more than 30 provisional patents and is now focusing its resources to advancing many of these patents to the next level.
Biomoda, Inc., 30% held directly and indirectly by ADOT, is proceeding with the raising of capital on its SB-2 registration filed and approved by the SEC. Biomoda, Inc. has commenced development of an ASR (Analyte Specific Reagent) approval level product. This is an approval route available in leading countries of Europe. Biomoda's ASR sales are estimated to approximate Biomoda bulk sales and is scheduled to move forward rapidly. Biomoda...
highbeam.com
GenoMed appeals to minorities to decrease deaths and suffering from kidney disease
New York Beacon, The; 2/25/2004
Read the Full Article, Get a FREE Trial for instant access »
HighBeam Research Members — Log in now
New York Beacon, The
02-25-2004
GenoMed, Inc., a Next Generation Disease Management company that uses its
expertise in disease-causing genes to improve patient outcomes, has
appealed to the nation's communities of color to consider GenoMed's
treatment for preventing kidney failure. The average Black American has a
ten-fold higher risk of kidney failure compared to the average White
American. The average life expectancy on kidney dialysis is less than five
years for all Americans. High blood pressure, a precursor to kidney disease
and the need for dialysis, is twice as prevalent among African Americans
compared to whites. So is type 2 diabetes, which is even more prevalent
among Hispanics and Native Americans. But a Black person with high blood
pressure or diabetes has a five times higher risk of ending up on kidney
dialysis than a white person with high blood pressure or diabetes.
Hispanics and Native Americans with diabetes also end... |
